Llagas, Rizelda .

HRN: 21-89-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2022
CEFUROXIME 1.5GM (VIAL)
09/20/2022
09/27/2022
IV
750 Mg
Q8
PROM , MSAF

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines